Mechanisms of p53 degradation

被引:106
作者
Chao, Chuck C. -K. [1 ,2 ]
机构
[1] Chang Gung Univ, Coll Med, Dept Biochem & Mol Biol, Taoyuan 333, Taiwan
[2] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan 333, Taiwan
关键词
De-ubiquitinating enzyme; E3; ligase; Mdm2; p53; Proteasome; Ubiquitin; UBIQUITIN-PROTEIN LIGASE; PROTEASOME-MEDIATED DEGRADATION; NERVOUS-SYSTEM DEVELOPMENT; SENSITIZES CANCER-CELLS; TUMOR-SUPPRESSOR P53; IN-VIVO; REGULATE P53; TRANSCRIPTIONAL ACTIVITY; DEUBIQUITINATING ENZYME; CDT1; PROTEOLYSIS;
D O I
10.1016/j.cca.2014.08.015
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The tumor suppressor p53 plays various functional roles in the cell by regulating multiple regulatory signals that ensure adequate temporal and spatial responses to cellular stress. p53 is usually kept inactive due to ubiquitination by a number of E3 ubiquitin ligases that target p53 for proteasomal degradation. The ubiquitously expressed proto-oncogene Mdm2 is the major E3 ubiquitin ligase involved in this process and is critical for regulating p53 homeostasis. Ubiquitination by E3 ligases may induce cellular relocation of p53 and determine the outcome of p53-mediated stress response, including cell proliferation, apoptosis and efficacy of cancer therapy. In addition to marking p53 for proteasomal degradation, ubiquitination acts as a signal for the degradation-independent functions of p53, such as nuclear export and transcriptional activation. Importantly, the reversible nature of the ubiquitination process and the identification of de-ubiquitination enzymes acting on p53 have added yet another layer of regulatory mechanism controlling p53 activity. This review highlights our current understanding of the mechanisms underlying p53 degradation as well as the significance of the p53 pathway in response to genotoxic stress. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 50 条
  • [21] Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation
    Neitzel, Carina
    Seiwert, Nina
    Goeder, Anja
    Diehl, Erika
    Weber, Carina
    Nagel, Georg
    Stroh, Svenja
    Rasenberger, Birgit
    Christmann, Markus
    Fahrer, Joerg
    [J]. CELLS, 2019, 8 (08)
  • [22] UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation
    Du, Cheng
    Wu, Hong
    Leng, Roger P.
    [J]. ONCOTARGET, 2016, 7 (03) : 2823 - 2836
  • [23] Anoikis triggers Mdm2-dependent p53 degradation
    Ghosh, Abhijit
    Chen, Tina Chunyuan
    Kapila, Yvonne L.
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2010, 343 (1-2) : 201 - 209
  • [24] Loss of Parkin reduces inflammatory arthritis by inhibiting p53 degradation
    Jung, Yu Yeon
    Son, Dong Ju
    Lee, Hye Lim
    Kim, Dae Hwan
    Song, Min Jong
    Ham, Young Wan
    Kim, Youngsoo
    Han, Sang Bae
    Park, Mi Hee
    Hong, Jin Tae
    [J]. REDOX BIOLOGY, 2017, 12 : 666 - 673
  • [25] Anoikis triggers Mdm2-dependent p53 degradation
    Abhijit Ghosh
    Tina Chunyuan Chen
    Yvonne L. Kapila
    [J]. Molecular and Cellular Biochemistry, 2010, 343 : 201 - 209
  • [26] Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation
    M M Candeias
    D J Powell
    E Roubalova
    S Apcher
    K Bourougaa
    B Vojtesek
    H Bruzzoni-Giovanelli
    R Fåhraeus
    [J]. Oncogene, 2006, 25 : 6936 - 6947
  • [27] Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress
    Ljungman, M
    [J]. NEOPLASIA, 2000, 2 (03): : 208 - 225
  • [28] Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation
    Candeias, M. M.
    Powell, D. J.
    Roubalova, E.
    Apcher, S.
    Bourougaa, K.
    Vojtesek, B.
    Bruzzoni-Giovanelli, H.
    Fahraeus, R.
    [J]. ONCOGENE, 2006, 25 (52) : 6936 - 6947
  • [29] Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines
    Fiamma Mantovani
    Lawrence Banks
    [J]. Oncogene, 1999, 18 : 3309 - 3315
  • [30] Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines
    Mantovani, F
    Banks, L
    [J]. ONCOGENE, 1999, 18 (22) : 3309 - 3315